Citadel Advisors
GRTS

Citadel Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Citadel Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-68,300
Closed -$39.6K – 15740
2024
Q3 		$39.6K Buy
68,300
+33,700
+97% +$18.9K ﹤0.01% 12152
2024
Q2 		$21.4K Sell
34,600
-138,700
-80% -$117K ﹤0.01% 12576
2024
Q1 		$445K Buy
173,300
+167,500
+2,888% +$409K ﹤0.01% 8650
2023
Q4 		$11.8K Sell
5,800
-700
-11% -$1.28K ﹤0.01% 13019
2023
Q3 		$11.2K Sell
6,500
-24,100
-79% -$42.8K ﹤0.01% 13023
2023
Q2 		$59.7K Sell
30,600
-98,800
-76% -$231K ﹤0.01% 11597
2023
Q1 		$360K Buy
129,400
+30,600
+31% +$87.4K ﹤0.01% 8993
2022
Q4 		$341K Buy
98,800
+19,400
+24% +$55.4K ﹤0.01% 9038
2022
Q3 		$204K Sell
79,400
-7,200
-8% -$22.9K ﹤0.01% 10369
2022
Q2 		$210K Buy
86,600
+34,500
+66% +$90.6K ﹤0.01% 10608
2022
Q1 		$215K Sell
52,100
-1,900
-4% -$10.1K ﹤0.01% 11355
2021
Q4 		$694K Sell
54,000
-8,800
-14% -$97.4K ﹤0.01% 8866
2021
Q3 		$678K Buy
62,800
+29,100
+86% +$265K ﹤0.01% 9152
2021
Q2 		$308K Buy
33,700
+4,000
+13% +$37K ﹤0.01% 11197
2021
Q1 		$280K Buy
+29,700
New +$409K ﹤0.01% 11019

Other funds holding GRTS

BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Citadel Advisors's GRTS Position: Q3 2024 in Review

Citadel Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 67,786 shares — an estimated $38K sold.

Citadel Advisors first reported a position in GRTS in Q3 2018 and held it in 22 quarters. The position peaked at $4.46M in Q4 2021. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

  • Citadel Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 67,786 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $38K.
  • Citadel Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 22 quarters.
  • Citadel Advisors's Gritstone bio, Inc. Common Stock position peaked at $4.46M in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.